Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for XWELL, Inc. (XWEL : NSDQ)

• Company Description    XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. Number of Employees: 280

• Price / Volume Information    Yesterday's Closing Price: $1.44 Daily Weekly Monthly 20 Day Moving Average: 91,995 shares Shares Outstanding: 8.44 (millions) Market Capitalization: $12.16 (millions) Beta: 1.01 52 Week High: $2.20 52 Week Low: $0.26 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 26.32% 20.15% 12 Week 5.88% -2.12% Year To Date 212.50% 189.30%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 254 WEST 31ST STREET 11TH FLOOR - NEW YORK,NY 10001 USA ph: 212-750-9595 fax: 309-410-3967 ir@xwell.com http://www.xwell.com

• General Corporate Information    Officers Ezra T. Ernst - Chief Executive Officer and Director Ian Brown - Chief Financial Officer Bruce T. Bernstein - Director Robert Weinstein - Director Michael Lebowitz - Director Peer Information XWELL, Inc. (CHCR) XWELL, Inc. (ESRX) XWELL, Inc. (MYDP) XWELL, Inc. (COR) XWELL, Inc. (GBCS) XWELL, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 98420U802 SIC: 7200 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 8.44 Most Recent Split Date: 9.00 (0.05:1) Beta: 1.01 Market Capitalization: $12.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.21 Price/Cash Flow: - Price / Sales: 0.42 EPS Growth vs. Year Ago Period: -51.00% vs. Previous Quarter: 54.10% Sales Growth vs. Year Ago Period: -5.48% vs. Previous Quarter: -7.21% ROE 03/31/26 - -2,318.99 12/31/25 - - 09/30/25 - -352.37 ROA 03/31/26 - -116.79 12/31/25 - -84.71 09/30/25 - -64.88 Current Ratio 03/31/26 - 2.35 12/31/25 - 0.46 09/30/25 - 1.08 Quick Ratio 03/31/26 - - 12/31/25 - 0.42 09/30/25 - 1.02 Operating Margin 03/31/26 - -81.43 12/31/25 - -58.17 09/30/25 - -51.85 Net Margin 03/31/26 - -81.43 12/31/25 - -58.17 09/30/25 - -51.85 Pre-Tax Margin 03/31/26 - -78.06 12/31/25 - -55.04 09/30/25 - -48.78 Book Value 03/31/26 - 1.19 12/31/25 - -2.11 09/30/25 - 0.53 Inventory Turnover 03/31/26 - 39.81 12/31/25 - 41.01 09/30/25 - 45.18 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - - 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - - 09/30/25 - 9.74

Powered by Zacks Investment Research ©